Insight and opinion
By Eddie Ryan, Chief Executive Officer, Kneat Solutions | First published on learnaboutgmp.com Companies operating in the life science industry…
Regulatory expectations related to GxP validation have increased in both inspection focus and in complexity. And it doesn’t get any easier when your company expands, with the related validation deliverables, effort and compliance risks increasing further.
In an effort to enhance consistent quality, address data integrity challenges, reduce costs, and minimize risk, Life Science companies are seeking to optimize their Validation processes. In doing so they naturally consider going paperless and typically look at an existing IT system, before considering a built for purpose paperless validation solution.
Data Integrity is a major concern for the global pharmaceutical and medical device industries, across many of their business areas. Global regulatory authorities have increased their inspection focus to ensure good Data Integrity practices are being implemented. The increased focus results from inspection observations of significant deficiencies.
Process validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process is capable of consistently delivering quality products.
Process validation involves a series of activities taking place over the lifecycle of the product and process.
It’s a question commonly asked in the validation arena, what is the difference between a FAT and a SAT. This article will finally explain what the difference is and why each one is required.
Talk to us
Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.